2022
DOI: 10.1016/j.lanepe.2022.100393
|View full text |Cite|
|
Sign up to set email alerts
|

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
31
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(32 citation statements)
references
References 36 publications
0
31
1
Order By: Relevance
“… 37 In contrast, 113 cases of MIS‐C were observed among one million SARS‐CoV‐2 infections in the same age group. 37 Evidence is starting to emerge that vaccination can reduce the risk of MIS‐C. 38 Prevention of MIS‐C is important because affected infants and adolescents may face long‐term health sequalae that are not yet known.…”
Section: Severe Disease From Covid Does Not Occur ...mentioning
confidence: 99%
“… 37 In contrast, 113 cases of MIS‐C were observed among one million SARS‐CoV‐2 infections in the same age group. 37 Evidence is starting to emerge that vaccination can reduce the risk of MIS‐C. 38 Prevention of MIS‐C is important because affected infants and adolescents may face long‐term health sequalae that are not yet known.…”
Section: Severe Disease From Covid Does Not Occur ...mentioning
confidence: 99%
“…One child had diabetes mellitus as an underlying disease that may decrease vaccine effectiveness [9]. Similarly, MIS-C cases with vaccination history before diagnosis are rarely reported [10][11][12][13][14][15], leading to physician concerns regarding vaccine effectiveness or potential COVID-19 vaccine-associated MIS-C.…”
Section: Department Of Pediatric Infectious Diseases University Of He...mentioning
confidence: 99%
“…Covid-19 vaccination could reduce incidence of severe disease among under 5s considered at highest risk15 and may protect them against the rarer multisystem inflammatory syndrome, as observed in children aged over 12 years 18. This complication has also been reported after covid-19 vaccination in older children, but at lower rates than occur following natural infection 19. Vaccination helps protect adults against prolonged symptoms such as fatigue and loss of smell, but rates of these longer term symptoms are low in children 20.…”
mentioning
confidence: 98%
“…18 This complication has also been reported after covid-19 vaccination in older children, but at lower rates than occur following natural infection. 19 Vaccination helps protect adults against prolonged symptoms such as fatigue and loss of smell, but rates of these longer term symptoms are low in children. 20 It will be some time before the long term effects of covid-19 (both direct and indirect) on under 5s are fully understood.…”
mentioning
confidence: 99%